Investment Q&A

Q: In part of your response to Graeme, earlier today, in regard to Concordia, you stated, "The equity deal allows current shareholders to sell and replace their shares with the financing (at a lower price)."

??????

Confused here.

As a current shareholder of CXR, how does this affect me? I am in for the long haul and have learned to live with the volatility, but I'm at a loss to know if anything needs to be done here.

Thanks for clearing this up, because everything is very muddy right now.

Thanks, as always, for your great service -- especially to those, like me, who are "challenged" when it comes to "investor-speak".

Q: Hi,

Why is it that a deal that should add value makes the stock drop 8%?

Thnqks

Q: Can you comment on CXR press release this morning on their acquisition? I'm underweight in this sector and want to add CXR depending on your feedback. Do you typically wait (a few days?)for the market to digest the news before buying? Thanks again - John.

Q: would you please give me your opinion on cipher pharmacy - I purchased it at $16.63 in December - should I hold or sell. Thank you.

Q: Just one more question on PHM! Could you advise the percentage of Shorts outstanding as of today. Thank you.

Q: How would you feel about buying IBB on this recent pullback? Already have CXR and PHM in the space. Or would you prefer IWO as a way to pick up a growthy etf at these lower levels? Already have VUN for broad U.S. exposure. How high of a weighting for either would you go up to for a young investor with a long timeframe? Cheers

Q: I wonder if you could comment on this US pharma stock which has just popped on purchase of another company. Is it on your radar?

Q: I submitted a question on INOGEN U.S. last Friday. Did you receive it?

Q: Some specifics on phm.

They did an offering a bit before the fuss.
1. Was the offering @ $1.50?
2. I believe there were restrictions on selling which I believe come off September 8. Is this correct?

3. Is it likely that some who bought the offering would be upset enough to sell at that time even though at a loss?

4. If they are selling, is it likely they would sell the first day possible or try to spread it out?

5. If spread out ,over what period?

Bryon in Elmira

Q: Dear Gentlemen,
if you cover Nobilis Health Corp. what is your opinion on this company,
also on the Health Care and Health Sciences Sector in general?

What is your research on Manulife Financial (MFC.TO)?
Would it be a good time to buy now? Thank you.

Q: My impression of the conference call is that:
1) they apologized and took responsibility for the meltdown but did not offer details as to what the original two still own, possibly because of legal advice or they just think it's been beaten to death.
2) the questions from three analysts - Mackie, Beacon and a third I didn't hear - were soft and supportive so, at least, they have not given up on this company and, in fact, congratulated the team on the latest acquisition.
3) the new people in charge will no longer promote LOI's but will only announced signed acquisitions while implementing new strategies to cross-sell in a more complete and continuing fashion with methods that were previously successful at Sleep Management.
4) Overall, there was an underlying sense that they know they made a massive error in judgement and who knows who benefited as the share price lately may prove to be a gift when you can buy a stock for 50 percent off when fundamentals haven't changed (forgive my cynicism but some made a lot of money on this charade and, I admit, I bought quite a few shares at around seventy cents) but the underlying theme that surfaced from each of four speakers is that they now know it's time to stop blowing their horn and get down to building a solid, profitable business in a $250B market and let their results speak for themselves. As John Templeton was famous for saying - "well done is better than well said".
I am sticking with them and in three years this will be a five dollar stock, in my view.
Thanks for the opportunity to provide some insight.
Steven

Q: Based on the release of restricted shares on Sept 5,what effect would you expect to both volume & share movement?
Thanks

Q: After backing off from it's highs this stock has commenced moving up aagain on considerable volume. Any observations, updates given the recent move?

Q: Latest deal ?

Q: Can I get your thoughts on GUD's latest transaction?

https://research.tdwaterhouse.ca/research/public/Markets/NewsArticle/100-243u7771-1

Q: Read your comments today re: the 6/30 quarter for PHM. However, since these statements are only INTERNAL, I would appreciate your opinion as to their veracity since the erstwhile Principals leave me somewhat uneasy and skeptical. Thank you.

Q: I bought PHM in April at $1.60. It has since plummeted to $ .60. I understand that averaging down is frequently like catching "falling knife" but with PHM now having recovered to $.80 I am considering "averaging down" and buying another 1000 shares. What is your opinion. Thanks

Q: Please comment on their results. Thanks

Q: Peter et al.

Any thoughts on this one. It is the rebranded Bioniche. They recently got an FDA notification that their bladder cancer drug (Urocidin) will get FDA fast-track review. They seem well cashed up, but do have a lot of shares outstanding (280 million). Thanks.

Q: What is your viewpoint on CRH Medical? Bought a half position this week at $4.80. I am looking at a 3 to 4 year hold on this one. I missed out on Concordia Healthcare as I would have liked to have bought it at $60 and it took off before I could. Could this be the next Concordia?

Regards,

Brendan